Effect of Mother's Push at Cesarean Delivery Mother's PUSHING AT CS A RANDOMIZED CONTROLLED TRIAL

August 25, 2022 updated by: Hannover Medical School

Effect of Mother's Active Pushing at Cesarean Delivery

The purpose of this study is to assess the safety and efficacy of the mother's active pushing during cesarean delivery.

Study Overview

Detailed Description

Patients, who are getting a scheduled cesarean section and having no contraindication for valsalva manoeuvres are eligible for this study. The gestational week should be between 37 and 42 weeks. Patients have to provide informed consent to this study. Patients must have epidural anaesthesia. They must understand the German language in order to understand information during cesarean section and correctly fill-out the questionnaires. Emergent cesarean sections or pregnant women known with chronic pain, severe preeclampsia or HELLP-Syndrome will be excluded.

179 patients were initially recruited, of which 79 were excluded. The 100 patients were grouped into two study groups; Conventional and Assisted Groups. The grouping was performed randomly using simple randomization. Based on the findings of Armbrust et al and our clinical experience we expect a therapeutic effect of 20% which results in a mean visual analog scale reduction of 1.2. Applying a two-sided T-Test for independent samples at a significance level of 0.05, a mean difference of 0.8 between the groups and a standard deviation of 2, we need 17 patients per treatment arm to detect a difference between both treatment groups with a power of 80%14. The number of patients per treatment arm was increased to 50 patients to make up for any missing data.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lower Saxony
      • Hanover, Lower Saxony, Germany, 30625
        • Hanover Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Minimum age of 18 years
  • Written consent
  • Pregnant women between 37 - 42 weeks
  • No fetal abnormalities.
  • Scheduled primary C-Section (category 3&4 NICE guidelines) with epidural anaesthesia

Exclusion Criteria:

  • Emergent cesarean section
  • Contraindication for epidural anaesthesia.
  • Multiple pregnancies
  • Scheduled C-section with placenta previa, accreta, increta or percreta. Secondary C-section
  • Contraindication for Valsalva manoeuvre
  • Known psychiatric illnesses
  • Known chronic Pain, taking Pain killers regularly
  • language barrier

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Conventional Group
Received a classic CS without intervention (Control group)
Experimental: Assisted group
after uterotomy during CS, the mother was instructed and motivated to push for the delivery of the head and the shoulders of the baby. Simultaneously, the surgical assistant applied fundal pressure to support the mothers pushing if necessary.
after uterotomy, the mother was instructed and motivated to push for the delivery of the head and the shoulders of the baby. Simultaneously, the surgical assistant applied fundal pressure to support the mothers pushing if necessary

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in postoperative pain of the mother
Time Frame: directly after delivery (intraoperative), 4-6 hours after delivery and on the first and second postoperative days
Discomfort and pain of the mother were assessed, on a 10-point Likert scale
directly after delivery (intraoperative), 4-6 hours after delivery and on the first and second postoperative days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence and quality of Breastfeeding
Time Frame: Postoperative day 0,1,2
Using the Breastfeeding Self-Efficacy Scale, Short Form (BSES-SF)
Postoperative day 0,1,2
Incidence of Postpartum Depression
Time Frame: Postoperative day 0,1,2
Using the Edinburgh Postnatal Depression Scale (EPDS)
Postoperative day 0,1,2
senses of participation and control
Time Frame: Intraoperative, directly after the baby delivery
Using likert scale. To determine the effect of the mother's push on the sense of control and participation. Studies showed that poor communications as well as fears of missing out on the birth are one of the main causes of distress during CS . Improving sense of control and participation will improve the birth experience .
Intraoperative, directly after the baby delivery
Different in the operation duration between the two groups
Time Frame: At end of the operation
Using the time , that was documented in the operation protocols
At end of the operation
Intensity of intraoperative fundal pressure
Time Frame: Intraoperative after the delivery of the baby
Using the Likert scale
Intraoperative after the delivery of the baby
Quantity of the Intraoperative maternal blood loss
Time Frame: Intraoperative - end of the operation
Quantity of blood loss that the surgeon has been estimated
Intraoperative - end of the operation
Rate of birth asphyxia
Time Frame: Intraoperative , directly after the baby delivery
Using APGAR score , PH sampling from umbilical cord (venous and arterial)
Intraoperative , directly after the baby delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Peter Hillemanns, Professor, Hannover Medical School
  • Principal Investigator: Stefan Engeli, Prof., Hannover Medical School (MHH)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2020

Primary Completion (Actual)

March 20, 2021

Study Completion (Actual)

March 20, 2021

Study Registration Dates

First Submitted

August 19, 2022

First Submitted That Met QC Criteria

August 25, 2022

First Posted (Actual)

August 30, 2022

Study Record Updates

Last Update Posted (Actual)

August 30, 2022

Last Update Submitted That Met QC Criteria

August 25, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caesarean Section

Clinical Trials on Mother's push during CS

3
Subscribe